Tiziana Life Sciences doses first ALS patients in Phase 2a Foralumab trial
Proactive - Interviews for investors · Proactive Investors
September 30, 20265m 26s
Audio is streamed directly from the publisher (cdn.simplecast.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.